Overview
- Products at 50 mg or less per recommended daily dose will remain in general retail, 50–200 mg will require pharmacist advice, and doses above 200 mg will need a prescription.
- The changes take effect on June 1, 2027 and will apply to roughly 125 products currently on the Australian market.
- The decision follows an amendment to the Poisons Standard after a safety review and public consultation that included more than 100 reports of severe adverse effects.
- Regulators are targeting cases of peripheral neuropathy linked to sustained high intake, as toxicity reports rise while deficiency in the general population remains uncommon.
- Consumers are urged to check labels for vitamin B6 (pyridoxine, pyridoxamine, pyridoxal), stop use and seek medical advice if tingling or numbness occurs, and report side effects to the TGA.